MedPath

Studying the Relationship Between Contact Lens Packaging Solutions and Bacterial Binding to Surface Eye Cells

Not Applicable
Withdrawn
Conditions
Corneal Ulcer
Registration Number
NCT01104961
Lead Sponsor
University of Texas Southwestern Medical Center
Brief Summary

The goal of this study is to investigate the overall theory that the use of chemically preserved solutions associated with contact lenses promotes an increase in bacterial infection.

Detailed Description

The purpose of this study is to investigate the theory of bacterial binding to surface eye cells through the use of chemically preserved solutions.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Age range: 18-38 years
  • Any sex, race or national origin accepted as with our past studies. Minority representation will be proactively encouraged.
  • No prior history of any contact lens wear within one month of entry into the study.
  • No history of allergic eye disease either seasonal or associated with previous contact lens wear.
Exclusion Criteria
  • Any patient that is a current contact lens wearer.
  • Patients with active ocular infection or inflammatory disease, history of herpetic keratitis, glaucoma, etc.
  • Uncontrolled systemic disease or the presence of any significant illness or condition that could, in the judgment of the investigator, interfere with interpretation of the study results.
  • Any patient using ocular tears, anti-histamine based ocular therapies, glaucoma therapy, vasoconstricting drops, etc.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Bacterial binding of Pseudomonas Aeruginosa5 weeks

Counting the number of bacteria that bind to surface epithelial cells.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UT Southwestern Medical Center

🇺🇸

Dallas, Texas, United States

UT Southwestern Medical Center
🇺🇸Dallas, Texas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.